Status:
RECRUITING
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
Lead Sponsor:
Boston Children's Hospital
Conditions:
Sepsis
Eligibility:
All Genders
2-50 years
Brief Summary
In this research study we want to learn more about the characteristics of neutrophils that are present in the blood and secretions from a breathing tube of patients with sepsis. Sepsis is a severe typ...
Eligibility Criteria
Inclusion
- Case
- sepsis patient in the ICU with a breathing tube
- Control
- scheduled for an elective surgical procedure and need preoperative blood draw or will have an intravenous catheter placed for the purpose of their surgical procedure
- Plan to have endotracheal tube for planned procedures.
Exclusion
- On chronic immunosuppressive drugs such as chronic corticosteroid use, or preexisting immunodeficiency diseases (oncology patients, patients with transplantation)
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04103281
Start Date
September 1 2020
End Date
December 31 2026
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115